Bensen Daniel

Chief Operating OfficerTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Nov 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2025Sell(S)2K$17.07$26K297K
Nov 17, 2025Sell(S)19K$16.11$299K298K
Nov 14, 2025Sell(S)110K$16.02$1.8M317K
Nov 13, 2025Sell(S)1K$16.00$18K427K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-284935) within minutes of acceptance. Every field above traces to the original document. Verify it directly: